The CRZ1/SP1-like gene links survival under limited aeration, cell integrity and biofilm formation in the pathogenic yeast Cryptococcus neoformans

Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2014 Jun;158(2):212-20. doi: 10.5507/bp.2013.024. Epub 2013 Apr 22.

Abstract

Aims: Limited aeration has been demonstrated to cause slowdown in proliferation and delayed budding, resulting eventually in a unique unbudded G2-arrest in the obligate aerobic pathogenic yeast Cryptococcus neoformans. Also, the ability to adapt to decreased oxygen levels during pathogenesis has been identified as a virulence factor in C. neoformans. The aim of this study was to identify and characterize genes that are necessary for the proliferation slowdown and G2-arrest caused by limited aeration.

Methods: Random mutants were prepared and screened for lack of typical slowdown of proliferation under limited aeration. The CNAG_00156.2 gene coding for a zinc-finger transcription factor was identified in mutants showing most distinctive phenotype. Targeted deletion strain and reconstituted strain were prepared to characterize and confirm the gene functions. This gene was also identified in a parallel studies as homologous both to calcineurin responsive (Crz1) and PKC1-dependent (SP1-like) transcription factors.

Results: We have confirmed the role of the cryptococcal homologue of CRZ1/SP1-like transcription factor in cell integrity, and newly demonstrated its role in slowdown of proliferation and survival under reduced aeration, in biofilm formation and in susceptibility to fluconazole.

Conclusions: Our data demonstrate a tight molecular link between slowdown of proliferation during hypoxic adaptation and maintenance of cell integrity in C. neoformans and present a new role for the CRZ1 family of transcription factors in fungi. The exact positioning of this protein in cryptococcal signalling cascades remains to be clarified.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anaerobiosis
  • Antifungal Agents / pharmacology
  • Biofilms / growth & development
  • Caenorhabditis elegans Proteins / genetics*
  • Cell Cycle Checkpoints / genetics
  • Cryptococcus neoformans / drug effects
  • Cryptococcus neoformans / genetics*
  • Cryptococcus neoformans / growth & development*
  • Fluconazole / pharmacology
  • Gene Deletion
  • Microbial Viability
  • Transcription Factors / genetics*

Substances

  • Antifungal Agents
  • Caenorhabditis elegans Proteins
  • Transcription Factors
  • Fluconazole